VERTEX PHARMACEUTICALS INC / MA Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant of 13.76 million shares as of 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant · last filed 2025-02-13
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 13.76M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 16.51M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 19.70M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 9.56M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant |
|---|---|
| 2024-12-31 | 13.76M shares 10-K · filed 2025-02-13 |
| 2023-12-31 | 16.51M shares 10-K · filed 2024-02-15 |
| 2022-12-31 | 19.70M shares 10-K · filed 2023-02-10 |
| 2021-12-31 | 9.56M shares 10-K · filed 2022-02-09 |
| 2020-12-31 | 13.39M shares 10-K · filed 2021-02-11 |
| 2019-12-31 | 15.78M shares 10-K · filed 2020-02-13 |
| 2018-12-31 | 14.74M shares 10-K · filed 2019-02-13 |
| 2017-12-31 | 11.43M shares 10-K · filed 2018-02-15 |
| 2016-12-31 | 9.18M shares 10-K · filed 2017-02-23 |
| 2015-12-31 | 14.12M shares 10-K · filed 2016-02-16 |
| 2014-12-31 | 10.55M shares 10-K · filed 2015-02-13 |
| 2013-12-31 | 5.41M shares 10-K · filed 2014-02-11 |
| 2012-12-31 | 5.75M shares 10-K · filed 2013-03-01 |
| 2011-12-31 | 8.63M shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |